Virbac operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Virbac with three other
companies in this sector in France:
sales of 789.60 million Euro [US$873.45 million]
of which 44%
(604.21 million Euro [US$668.37 million]
of which 52%
was OTC Specialities and Other Products), and
(367.94 million Euro [US$407.01 million]
of which 55%
Virbac reported sales of 868.93 million Euro (US$961.20 million)
December of 2018.
a very small
increase of 0.8%
versus 2017, when the company's sales were 861.88 million Euro.
Despite this increase, sales are still
below the level achieved in 2016, when Virbac
reported sales of 871.83 million Euro.
Sales of Companion Animals saw an increase
that was more than double the company's growth rate: sales were up
4.0% in 2018, from
475.40 million Euro to 494.20 million Euro.
Not all segments of Virbac experienced an increase in sales in 2018:
sales of Food Productsing Animals fell 3.0% to 363.80 million Euro.
Virbac also experienced decreases in sales in
Other Activities (down 1.8% to 11.00 million Euro)